1. Matsuzawa-Ishimoto, Yu, Yao, Xiaomin, Koide, Akiko, Koide, Shohei, Cadwell, Ken. 2022. The γδ IEL effector API5 masks genetic susceptibility to Paneth cell death. In Nature, 610, 547-554. doi:10.1038/s41586-022-05259-y. https://pubmed.ncbi.nlm.nih.gov/36198790/
2. Noh, Kyung Hee, Kim, Seok-Ho, Kim, Jin Hee, Lee, Kyung-Mi, Kim, Tae Woo. 2014. API5 confers tumoral immune escape through FGF2-dependent cell survival pathway. In Cancer research, 74, 3556-66. doi:10.1158/0008-5472.CAN-13-3225. https://pubmed.ncbi.nlm.nih.gov/24769442/
3. Basset, Céline, Bonnet-Magnaval, Florence, Navarro, Marina Garcia-Jove, Garmy-Susini, Barbara, Lacazette, Eric. 2017. Api5 a new cofactor of estrogen receptor alpha involved in breast cancer outcome. In Oncotarget, 8, 52511-52526. doi:10.18632/oncotarget.17281. https://pubmed.ncbi.nlm.nih.gov/28881748/
4. Song, Kwon-Ho, Kim, Seok-Ho, Noh, Kyung Hee, Jeon, Ju-Hong, Kim, Tae Woo. . Apoptosis Inhibitor 5 Increases Metastasis via Erk-mediated MMP expression. In BMB reports, 48, 330-5. doi:. https://pubmed.ncbi.nlm.nih.gov/25248562/
5. Garcia-Jove Navarro, Marina, Basset, Céline, Arcondéguy, Tania, Prats, Hervé, Lacazette, Eric. 2013. Api5 contributes to E2F1 control of the G1/S cell cycle phase transition. In PloS one, 8, e71443. doi:10.1371/journal.pone.0071443. https://pubmed.ncbi.nlm.nih.gov/23940755/